Taniyama, Yusuke
Murakami, Kentaro
Yoshida, Naoya
Takahashi, Kozue
Matsubara, Hisahiro
Baba, Hideo
Kamei, Takashi
Article History
Received: 25 May 2021
Accepted: 29 August 2021
First Online: 9 September 2021
Declarations
:
: This study was approved by the appropriate ethics committees (approval numbers: 2020–1-114 [Tohoku Certified Review Board of Tohoku University], 2011 [Kumamoto University Certified Clinical Research Review Board], and 19374 [Chiba University Hospital Certified Clinical Research Review Board]), and the need for written informed consent from the patients was waived by the same ethics committee that approved the study. This study was conducted in accordance with the ethical standards of the Declaration of Helsinki of 1975.
: Not applicable.
: Naoya Yoshida belongs to a department supported by Chugai Pharmaceutical Co., Ltd. and Yakuruto Honsya Co., Ltd., but has no conflict of interest to declare regarding this research. Yusuke Taniyama, Kentaro Murakami, Kozue Takahashi, Hisahiro Matsubara, Hideo Baba, and Takashi Kamei declare that they have no conflict of interest.